Insider Transactions in Q2 2024 at Integra Lifesciences Holdings Corp (IART)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 23
2024
|
Stuart Essig Exec. Chairman of the Board |
BUY
Open market or private purchase
|
Direct |
52,641
+9.74%
|
$1,473,948
$28.49 P/Share
|
|
May 21
2024
|
Barbara B Hill Director |
BUY
Open market or private purchase
|
Indirect |
36,350
+50.0%
|
$981,450
$27.4 P/Share
|
|
May 12
2024
|
Keith Bradley Director |
SELL
Payment of exercise price or tax liability
|
Direct |
239
-0.17%
|
$5,975
$25.99 P/Share
|
|
May 09
2024
|
Stuart Essig Exec. Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
13,835
+0.73%
|
-
|
|
May 09
2024
|
Barbara B Hill Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,859
+5.66%
|
-
|
|
May 09
2024
|
Jeffrey A Graves Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,278
+35.22%
|
-
|
|
May 09
2024
|
Shaundra Clay Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,696
+28.4%
|
-
|
|
May 09
2024
|
Renee Wonlai Lo Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,696
+35.0%
|
-
|
|
May 09
2024
|
Raymond G. Murphy Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,696
+13.87%
|
-
|
|
May 09
2024
|
Christian S Schade Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,696
+12.04%
|
-
|
|
May 09
2024
|
Keith Bradley Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,696
+11.03%
|
-
|